Autoimmune Hemolytic Anemia Developing Secondary to Epstein-Barr Virus Infection: A case report

Year 2020, Volume: 5 Issue: 1, 199 - 202, 31.03.2020

Nevin İnce Elif Çelik Birgül Öneç Hilal Şöhret Uyanık

https://doi.org/10.26453/otjhs.637602

Abstract

Infectious mononucleosis (EM) is a disease characterized by irradiation of the Epstein-Barr virus (EBV). The clinical manifestation is characterized by tonsillopharyngitis, lym-phadenopathy and atypical lymphocytosis. We describe a young patient developing hemolytic anemia during follow-up in our clinic due to tonsillopharyngitis secondary to EBV and general condition disorder.

Keywords

Autoimmune, Hemolytic anemia, Infectious mononucleosis

Epstein-Barr Virus İnfeksiyonuna Sekonder Olarak Gelişen Otoimmun Hemolitik Anemi: Bir Vaka Raporu

Abstract

Enfeksiyöz mononükleoz (EM), Epstein-Barr virüsünün (EBV) yayılması ile karakterize bir hastalıktır. Klinik bul-gular tonsillofarenjit, lenfadenopati ve atipik lenfositoz ile karakterizedir. EBV'ye sekonder tonsillofarenjit ve genel durum bozukluğu nedeniyle kliniğimizde takip sırasında hemolitik anemi gelişen genç bir hastayı tanımladık.

Keywords

Autoimmune, Hemolytic anemia, Infectious mononucleosis

References

• 1. Johannsen EC, Schooley RT, Kaye KM. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2005:1801-20.
• 2. Arman D. Epstein-Barr virüs. Topçu Wilke A, Söyletir G, Doğanay M (editörler). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, 2002:1197-201.
• 3. Lennon P, Saunders J, Fenton JE. A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20- year period. J Laryngol Otol. 2013;7:1-5.
• 4. Cohen JI. Treatment of infectious mononucleosis: When and how? The Herpes Monitor. 2003;3:1-5.
• 5. Straus SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: Biology, pathogenesis and management. Ann Intern Med. 1993;118:45-58.
• 6. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-bind, plasebocontrolled study. J Infect Dis. 1996;174:324-31.
• 7. H.B. Jenson. Acute complications of Epstein–Barr virus infectious mononucleosis. Curr Opin Pediatr. 12 (2000), pp. 263-268.
• 8. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014:1457-1554.
• 9. E. C. Besa, Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. The American Journal of Medicine. 1988:691-8.
• 10. Vouloumanou E.K, Rafailidis P.I, Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20.